CD274 and non-small cell lung carcinoma: Similarly, in the BIRCH trial which studied PD-L1 inhibitor treatment in NSCLC, a significant association between treatment response and PD-L1 expression was noted, however there was no association between PD-L1 expression and irAEs (25).